Icon

TEGSEDI (nda211172)- (EQ 284MG BASE/1.5ML (EQ 189.3MG BASE/ML))

INOTERSEN SODIUM AKCEA THERAPS
EQ 284MG BASE/1.5ML (EQ 189.3MG BASE/ML)
No No
2031-Apr-29 2023-Oct-05
None None
None No
TEGSEDI is a transthyretin-directed antisense oligonucleotide indicated for treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults.
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 284MG BASE/1.5ML (EQ 189.3MG BASE/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.